You have 9 free searches left this month | for more free features.

Synribo

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +28 more
Dec 1, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +31 more
Nov 11, 2021

Acute Myelogenous Leukemia (AML) Trial in Atlanta (Omacetaxine)

Terminated
  • Acute Myelogenous Leukemia (AML)
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Sep 5, 2019

Leukemia Trial in Houston (Omacetaxine, Decitabine)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 9, 2018

MDS Trial in Gainesville (Omacetaxine, Azacitidine, G-CSF)

Withdrawn
  • Myelodysplastic Syndromes
  • Gainesville, Florida
    University of Florida Health Shands Cancer Hospital
May 1, 2017